Thymalin is a standardized bovine thymus polypeptide extract studied for T-cell maturation support and immune reconstitution. Part of the Khavinson bioregulator series for thymic involution and aging immunology research.
Thymalin is a purified polypeptide preparation derived from bovine thymus tissue through controlled enzymatic hydrolysis, yielding a standardized complex of low-molecular-weight peptides (predominantly under 10 kDa). The thymus gland is the primary site of T-lymphocyte development, where immature thymocytes undergo positive and negative selection to produce a diverse, self-tolerant T-cell repertoire. With aging, the thymus undergoes progressive involution — shrinking and being replaced by adipose tissue — resulting in declining thymic output (reduced recent thymic emigrants and naïve T cells), a phenomenon that contributes significantly to age-related immune dysfunction (immunosenescence).
Research applications for Thymalin center on thymic biology, T-cell homeostasis, and immune aging. Published studies from the Khavinson laboratory have investigated Thymalin in models of age-related thymic involution, immunoreconstitution following immune depletion, CD4/CD8 T-cell ratio normalization, natural killer cell cytotoxicity modulation, and cytokine balance restoration. The bioregulatory framework proposes that thymic peptides function as endogenous homeostatic signals that maintain tissue-specific function — in this case, thymic epithelial cell support and thymocyte development.
Thymalin has been studied alongside other thymic peptides (Thymosin Alpha-1, Thymosin Beta-4) to compare mechanisms and efficacy in immune restoration paradigms. While Thymosin Alpha-1 is a single defined 28-amino acid peptide, Thymalin represents a complex multi-peptide preparation, potentially providing broader coverage of thymic signaling pathways.
Supplied as a lyophilized powder. Store at 2-8°C. For immunology and thymic biology research only.